Homeopathic advice now available on Aisle5
Aisle7 and Boiron last month partnered on the Aisle7 Online Decision Support Tools, an online decision support engine to provide science-based, self-care homeopathic product recommendations. Called the Homeopathic Medicine Finder, the Boiron-branded tool enables consumers to filter through more than 350 health conditions and symptoms to find the right product.
The new tool will be featured across more than 2,000 in-store retail locations and 150 websites served by Aisle7.
“In particular for homeopathy, which in some cases is kind of a new category for people, … it’s really a new way to think about treatment,” said Bill Schneider, Aisle7 spokesman. “This product helps them cut through all the confusion and links them specifically with the product to consider for a condition.”
According to Pew Research, more than half of consumers regularly use the Internet to research and choose products to buy. “Traffic to [Aisle7] pages is on a 20% year-over-year growth rate as more and more people are starting to realize [their] retailers are featuring more content on their site,” Schneider said.
Allergy: Arkansas considers PSE switch to Rx-only
As Drug Store News suggested last month, legislation under consideration in Tennessee and Kentucky that would make the popular decongestant pseudoephedrine only available by prescription has, in fact, sparked interest in neighboring states. Arkansas shares a border with Kentucky, where a PSE prescription-only bill was filed in January, and Mississippi, one of two states that already has passed PSE prescription-only legislation.
Nationally, sales of the top-three best-selling PSE products — Claritin-D, Mucinex D and Zyrtec-D — were up 4.3% to $62.1 million across food, drug and mass (minus Walmart) for the 12 weeks ended Jan. 23, according to SymphonyIRI Group data.
Sales of all cough-cold products were up 6.8% to $1.4 billion. Heading into March, between 14% and 16% of the population were experiencing an upper respiratory ailment, according to the Chestal Cold & Flu Tracker sourcing SDI data.
The article above is part of the DSN Category Review Series. For the complete Allergy Sell-Through Report, including extensive charts, data and more analysis, click here.
Homeopathy profits from PSE recalls
BUFFALO, N.Y. — Last year’s recalls have put many popular children’s cough-cold medicines in the headlines and off the shelves. Couple that factor with the debate over safety and efficacy of these products, and you have a market primed for just as efficacious but safer introductions, like those in the homeopathic sector.
“The past issues with pediatric cold medicines have been great for homeopathy and the natural segment,” said Michele Boisvert, Homeolab USA president. “There is certainly an increased amount of homeopathic and natural offerings on the shelves today for consumers to choose from,” she said. “And now with recent recalls, it leaves the door wide open for natural options.”